Thursday, January 27, 2022 Daily Archives

Accelerate Biologic Process Development and GMP Manufacturing Using In-Line Concentration Measurement

by

This webcast features: Ramsey Shanbaky, Associate Director, Bioprocess Applications, Repligen In-process measurement is the key to process monitoring and control. It can save time and money by helping you identify key aspects of your process in real-time. In this webcast, we will demonstrate how the CTech™ FlowVPX™ Slope Spectroscopy System, when directly integrated in one or more locations of a process stream, has helped reveal process characteristics that until now have been hidden due to the limitations of the most…

January 27, 2022

Facilitating Workforce Development: A case study on improving single-use training through vendor and end-user collaboration

by and

Discover how Pall Corporation and Lonza collaborated to improve single-use technology training for operators using a blended approach to learning. This article presents: The importance of SUT training for operators. Why a blended approach ensures that operators get the training they need in the format that best suits their learning style. How collaboration between suppliers and biomanufacturers can shorten training program development timelines and increase the quality of training tools. How Pall and Lonza developed a digital training approach together.…

January 27, 2022

CDMO Arranta buys Cytiva single-use tech for mRNA production

by

Live biologics CDMO Arranta Bio has bought a single-use manufacturing platform from Cytiva for the production of mRNA vaccines.  The purchase is part of a $110 million investment by Arranta at its manufacturing and development facility in Watertown, Massachusetts. The CDMO also plans to open a dedicate space for lipid nanoparticle formulation  Joe Makowiecki from Cytiva, told us “This is the first FlexFactory for an mRNA product,†adding that it will “provide Arranta the flexibility to manufacture mRNA vaccines and therapies from in vitro transcription (IVT) to drug product aseptic fill.    He predicted that…

January 27, 2022

Fujifilm Dio signs long term supply deal and buys plant from Atara

by

Fujifilm Diosynth Biotechnologies will buy Atara Biotherapeutics’ T-Cell operations and facility in Thousand Oaks, California for $100 million.  The deal will also see the contract development and manufacturing organization (CDMO) sign a long-term supply agreement covering both clinical and commercial production of Atara’s range allogeneic cell therapies.   Specific candidates will include tabelecleucel, ATA188 for multiple sclerosis and the allogeneic CAR T therapies, ATA3271 and ATA3219. Fujifilm Diosynth Biotechnologies also said it will expand use of the Thousand Oaks facility – which is known as ATOM – to manufacture a…

January 27, 2022